Home » Topics » BioWorld Science

BioWorld Science
RSS

RAGE-silencing RNAi suppresses pulmonary allergic inflammation

May 31, 2022

PharmEnable and Denali Therapeutics to collaborate in neurodegenerative disease research

May 31, 2022

New CD73 inhibitors patented by Humanwell Healthcare

May 31, 2022

Boehringer Ingelheim presents new indoleamine 2,3-dioxygenase 1 inhibitors

May 31, 2022

New menin/MLL interaction inhibitors synthesized at Shanghai Euregen Biopharma

May 31, 2022

Suzhou Yabao Pharmaceutical Research and Development patents mutant LRRK2 inhibitors

May 31, 2022

SLC13A5 inhibitors identified at the Rosalind Franklin University of Medicine and Science

May 31, 2022

Glycoengineering improves the anti-inflammatory effects of small extracellular vesicles

May 31, 2022

NRG Therapeutics receives Biomedical Catalyst award for neurodegenerative disorders

May 31, 2022

Discovery of novel orally bioavailable SERD with enhanced pharmacological properties

May 31, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...